Skip to content

Comparing the effects of tapering fentanyl and midazolam vs changing fentanyl and midazolam to dexmedetomidine on restlessness of patients being weaned from ventilator in PICU

Comparing the effects of tapering fentanyl and midazolam versus changing fentanyl and midazolam to dexmedetomidine on restlessness of patients being weaned from ventilator in PICU

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211221053474N1
Enrollment
20
Registered
2022-03-05
Start date
2023-03-06
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Restlessness of patients being weaned from ventilator in PICU. Condition 2: Dependence on sedative hypnotics. Dependence on respirator [ventilator] status Sedative, hypnotic or anxiolytic dependence, uncomplicated

Interventions

Intervention 1: Control group: In 10 patients who have been treated with midazolam and fentanyl for more than 5 days and are being weaned from the ventilator
according to diagnosis of pediatric pulmonologist, dose of midazolam and fentanyl will be reduced 10 to 25% per day based on patient's tolerance
at first dose of midazolam will be stopped and then fentanyl. Intervention 2: Experimental group: In 10 patients who have been treated with midazolam and fentanyl for more than 5 days and are being w
according to the diagnosis of pediatric pulmonologist, 24 hours before tapering midazolam and fentanyl, dexmedetomidine will be started at a dose of 0.2 to 0.5 mcg/kg/hour after 24 hours, midazolam an
then the dose of dexmedetomidine will be reduced 0.1 mcg/kg/hour depending on the patient's tolerance every 12 to 24 hours.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 18 Years

Inclusion criteria

Inclusion criteria: Receiving midazolam and fentanyl as sedatives hypnotics Children are being weaned from the ventilator

Exclusion criteria

Exclusion criteria: Decreasing blood pressure according to age range Bradycardia according to age range

Design outcomes

Secondary

MeasureTime frame
Reducing duration of the patient's weaning from the ventilator. Timepoint: Daily. Method of measurement: Demographic data including age, sex, weight, BMI and clinical data including blood pressure, respiration rate, oxygen saturation and body temperature; also data related to patients' blood gases will be recorded and compared in two groups.

Primary

MeasureTime frame
Reducing restlessness signs and symptoms in children; According to the Richmond Agitation-Sedation Scale (RASS), the patient's clinical score should be "zero". Timepoint: Daily. Method of measurement: The Richmond Scale is used to assess the reduction of restlessness symptoms and signs. According to this scale the "zero" clinical score indicates alert and calm patient.;Reducing the restlessness symptoms and signs in children that according to the Ramsay scale the patient's clinical score should be "two". Timepoint: Daily. Method of measurement: Data related to the patients' restlessness will be assessed and recorded using the Ramsay sedation scale and compared between two groups." two" clinical score indicates that the patient is awake, corporative, oriented, and tranquil.;Reducing restlessness symptoms in children, that is considered due to patient's clinical score in the Finnegan Neonatal Abstinence scores scale. Timepoint: Daily. Method of measurement: According to Finnegan Neonatal Abstinence scoring system, the patient's clinical score for autonomic nervous system, metabolic and gastrointestinal disorders will be recorded and assessed.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ghafuryan

Tabriz University of Medical Sciences

fatemeh.ghafuryan@gmail.com+98 87 3421 4756

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026